Klinische Studien

SANO (Strukturierte ambulante Nachsorge nach Schlaganfall): multizentrische cluster-randomisierte, kontrollierte, pragmatische Interventionsstudie zur Verbesserung der Sekundärprävention im ersten Jahr nachischämischen Schlaganfall durch ein sektorenübergreifendesstrukturiertes Nachsorgeprogramm (SNP)

INTREPID (Impact of Fever Prevention in Brain Injured Patients): randomized, controlled multicenter clinical investigation designed to assess fever burden and early, short- and long-term clinical outcomes of fever prevention (FP) using the Arctic Sun 5000 Temperature Management System (test device) compared to standard fever care (control device(s)) in the treatment of moderate-to-severe brain injured patients.

XATOA (Xarelto + Acetylsalicylic Acid): Treatment patterns and Outcomes in patients with Atherosclerosis. A non-interventional study. The study aims to collect real-world data on treatment patterns and decision points for treatment in patients with coronary artery disease (CAD) or symptomatic peripheral artery disease (PAD) treated with rivaroxaban 2.5 mg[BID] for the prevention of atherothrombotic events in adult patients at high risk of ischaemic events and to describe outcomes of an antithrombotic regime based on dual pathway inhibition (vascular dose of rivaroxaban 2.5 mg [BID] plus low-dose ASA [OD]) across the broad range of patient risk profiles encountered in routine clinical practice.

COTTIS -Trial 1–(COmbination of TTM and thrombectomy after acute ischemic stroke)  – a pilot feasibility and safety study – planning phase

Informationen/Kontakt:

Lisa Mäder
Studienärztin, Assistenzärztin in Weiterbildung zur Fachärztin Neurologie

Brigitte Gaudes
Studienschwester

Prof. Dr. Kollmar
Direktor der Klinik für Neurologie und Neurointensivmedizin

Tel.: 0 61 51 / 107 - 4500
Fax: 0 61 51 / 107 - 4599 

Rainer.Kollmar@mail.klinikum-darmstadt.de